Protein kinase C (PKC) has attracted extraordinary research interest over the past decade, resulting in a wealth of information about its structure and function. Our emerging understanding suggests, not surprisingly, that the initial models for activation and function were simplistic and possibly mi
Activation of Protein C Pathway in the Airways
β Scribed by O. Hataji; O. Taguchi; E.C. Gabazza; H. Yuda; H. Fujimoto; K. Suzuki; Y. Adachi
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 173 KB
- Volume
- 180
- Category
- Article
- ISSN
- 0341-2040
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Tamoxifen (TAM) is the endocrine therapeutic agent the most widely used in the treatment of breast cancer, and it operates primarily through the induction of apoptosis. In this study, we attempted to elucidate the nonβER mediated mechanism behind TAM treatment, involving the phospholipa
Imidazoline receptor antisera-selected protein (IRAS) is considered as a candidate for the I1-imidazoline receptor (I1R), but the signaling pathway mediated by IRAS remains unknown. In our study, the signal transduction pathways of IRAS were investigated in CHO cells stably expressing IRAS (CHO-IRAS
## Abstract ## Background Polyol pathway hyperactivityβinduced decreases in protein kinase C (PKC) activities have been proposed as a pathogenic mechanism of diabetic neuropathy. Increased PKC activities have recently been invoked in the pathogenesis of other diabetic complications, especially ret